A high-throughput respirometric assay for mitochondrial biogenesis and toxicity

Analytical Biochemistry

Volumn 404, Issue 1, 2010, Pages 75-81

  Beeson, Craig C ^a   Beeson, Gyda C ^a   Schnellmann, Rick G ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Biogenesis; Nephrotoxic; Oxygen consumption; Proximal tubule

Indexed keywords

BIOSYNTHESIS; CELL CULTURE; CELL DEATH; ELECTRON TRANSPORT PROPERTIES; FLAVONOIDS; MERCURY COMPOUNDS; METABOLISM; TOXICITY;

BIOGENESIS; ELECTRON TRANSPORT CHAIN; MITOCHONDRIAL BIOGENESIS; MITOCHONDRIAL FUNCTION; NEPHROTOXIC; OXYGEN CONSUMPTION; PROXIMAL TUBULES; RENAL PROXIMAL TUBULAR CELLS;

MITOCHONDRIA;

4 IODO 2,5 DIMETHOXYAMPHETAMINE; CARBONYL CYANIDE 4 (TRIFLUOROMETHOXY)PHENYLHYDRAZONE; CISPLATIN; DAIDZEIN; GENTAMICIN; MERCURY CHLORIDE; METFORMIN; RESVERATROL; 4-IODO-2,5-DIMETHOXYPHENYLISOPROPYLAMINE; AMPHETAMINE DERIVATIVE; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; CARBONYLCYANIDE 4-TRIFLUOROMETHOXYPHENYLHYDRAZONE; MERCURIC CHLORIDE; MULTIENZYME COMPLEX;

AEROBIC METABOLISM; ANALYZER; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL TISSUE; ARTICLE; BIOGENESIS; CELL DEATH; CELL ISOLATION; CELL VIABILITY; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ELECTRON TRANSPORT; FEMALE; FLUORESCENCE; KIDNEY TUBULE CELL; MITOCHONDRIAL RESPIRATION; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RABBIT; RESPIROMETRY; ANALOGS AND DERIVATIVES; ANIMAL; APOPTOSIS; CELL CULTURE; CELL RESPIRATION; CYTOLOGY; DRUG EFFECTS; HIGH THROUGHPUT SCREENING; KIDNEY PROXIMAL TUBULE; METABOLISM; MITOCHONDRION; OXYGEN CONSUMPTION; PROCEDURES; SMEGMAMORPHA; TOXICITY;

AMPHETAMINES; ANIMALS; ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARBONYL CYANIDE M-CHLOROPHENYL HYDRAZONE; CELL RESPIRATION; CELLS, CULTURED; CISPLATIN; ELECTRON TRANSPORT CHAIN COMPLEX PROTEINS; GENTAMICINS; HIGH-THROUGHPUT SCREENING ASSAYS; KIDNEY TUBULES, PROXIMAL; MERCURIC CHLORIDE; MITOCHONDRIA; OXYGEN CONSUMPTION; SMEGMAMORPHA;

EID: 77954177589     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2010.04.040     Document Type: Article

References (28)

1. Dekant W. Biotransformation and renal processing of nephrotoxic agents. Arch. Toxicol. Suppl. 1996, 18(Suppl.):163-172.
2. Pfaller W., Gstraunthaler G. Nephrotoxicity testing in vitro: what we know and what we need to know. Environ. Health Perspect. 1998, 106(Suppl. 2):559-569.
3. Hall A.M., Unwin R.J. The not so " mighty chondrion": emergence of renal diseases due to mitochondrial dysfunction. Nephron Physiol. 2007, 105:1-10.
4. Rasbach K.A., Schnellmann R.G. Signaling of mitochondrial biogenesis following oxidant injury. J. Biol. Chem. 2007, 282:2355-2362.
5. Rasbach K.A., Schnellmann R.G. PGC-1α over-expression promotes recovery from mitochondrial dysfunction and cell injury. Biochem. Biophys. Res. Commun. 2007, 13:734-739.
6. Rasbach K.A., Schnellmann R.G. Isoflavones promote mitochondrial biogenesis. J. Pharmacol. Exp. Ther. 2008, 325:536-543.
7. Funk J.A., Odejinmi S., Schnellmann R.G. SRT1720 induces mitochondrial biogenesis and rescues mitochondrial function after oxidant injury in renal proximal tubule cells. J. Pharmacol. Exp. Ther. 2010, 333:593-601.
8. Houck K.A., Kavlock R.J. Understanding mechanisms of toxicity: insights from drug discovery research. Toxicol. Appl. Pharmacol. 2008, 227:163-178.
9. Nowak G., Schnellmann R.G. Improved culture conditions stimulate gluconeogenesis in primary cultures of renal proximal tubule cells. Am. J. Physiol. 1995, 268:C1053-C1061.
10. Nowak G., Schnellmann R.G. L-Ascorbic acid regulates growth and metabolism of renal cells: improvements in cell culture. Am. J. Physiol. 1996, 271:C2072-C2080.
11. Ferrick D.A., Neilson A., Beeson C. Advances in measuring cellular bioenergetics using extracellular flux. Drug Discov. Today 2008, 13:268-274.
12. 2 respiration, reduced ATP utilization, and inducible fumarate respiration. Am. J. Phys. 2008, 295:C29-C37.
13. Gerencser A.A., Neilson A., Choi S.W., Edman U., Yadava N., Oh R.J., Ferrick D.A., Nicholls D.G., Brand M.D. Quantitative microplate-based respirometry with correction for oxygen diffusion. Anal. Chem. 2009, 81:6868-6878.
14. Affourtit C., Brand M.D. Measuring mitochondrial bioenergetics in INS-1E insulinoma cells. Methods Enzymol. 2009, 457:405-424.
15. Hunter G.R., Bamman M.M., Larson-Meyer D.E., Joanisse D.R., McCarthy J.P., Blaudeau T.E., Newcomer B.R. Inverse relationship between exercise economy and oxidative capacity in muscle. Eur. J. Appl. Physiol. 2005, 94:558-568.
16. Soltoff S.P., Mandel L.J. Active ion transport in the renal proximal tubule: I. Transport and metabolic studies. J. Gen. Physiol. 1984, 84:601-622.
17. Gnaiger E. Oxygen conformance of cellular respiration: a perspective of mitochondrial physiology. Adv. Exp. Med. Biol. 2003, 543:39-55.
18. Kramer J.A., Pettit S.D., Amin R.P., Bertram T.A., Car B., Cunningham M., Curtiss S.W., Davis J.W., Kind C., Lawton M., Naciff J.M., Oreffo V., Roman R.J., Sistare F.D., Stevens J., Thompson K., Vickers A.E., Wild S., Afshari C.A. Overview on the application of transcription profiling using selected nephrotoxicants for toxicology assessment. Environ. Health Perspect. 2004, 112:460-464.
19. Thukral S.K., Nordone P.J., Hu R., Sullivan L., Galambos E., Fitzpatrick V.D., Healy L., Bass M.B., Cosenza M.E., Afshari C.A. Prediction of nephrotoxicant action and identification of candidate toxicity-related biomarkers. Toxicol. Pathol. 2005, 33:343-355.
20. Wang E.J., Snyder S.D., Fielden M.R., Smith R.J., Gu Y.Z. Validation of putative genomic biomarkers of nephrotoxicity in rats. Toxicology 2008, 246:91-100.
21. Schnellmann R.G. Measurement of oxygen consumption. Methods of Toxicology: In Vitro Toxicity Indicators 1994, vol. 1, part B:128-139. Academic Press, San Diego.
22. Kukidome D., Nishikawa T., Sonoda K., Imoto K., Fujisawa K., Yano M., Motoshima H., Taguchi T., Matsumura T., Araki E. Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells. Diabetes 2006, 55:120-127.
23. Milne J.C., Lambert P.D., Schenk S., Carney D.P., Smith J.J., Gagne D.J., Jin L., Boss O., Perni R.B., Vu C.B., Bemis J.E., Xie R., Disch J.S., Ng P.Y., Nunes J.J., Lynch A.V., Yang H., Galonek H., Israelian K., Choy W., Iffland A., Lavu S., Medvedik O., Sinclair D.A., Olefsky J.M., Jirousek M.R., Elliott P.J., Westphal C.H. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 2007, 29:712-716.
24. Rasbach K.A., Funk J.A., Jayavelu T., Green P.T., Schnellmann R.G. 5-Hydroxytryptamine receptor stimulation of mitochondrial biogenesis. J. Pharmacol. Exp. Ther. 2010, 332:632-639.
25. Dykens J.A., Will Y. The significance of mitochondrial toxicity testing in drug development. Drug Discov. Today 2007, 12:777-785.
26. National Research Council, Committee on Toxicity Testing and Assessment of Environmental Agents, Toxicity Testing in the 21st Century: A Vision and a Strategy, National Academies Press, Washington, DC, 2007.
27. Inglese J., Auld D.S., Jadhav A., Johnson R.L., Simeonov A., Yasgar A., Zheng W., Austin C.P. Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries. Proc. Natl. Acad. Sci. USA 2006, 103:11473-11478.
28. Xia M., Huang R., Witt K.L., Southall N., Fostel J., Cho M.H., Jadhav A., Smith C.S., Inglese J., Portier C.J., Tice R.R., Austin C.P. Compound cytotoxicity profiling using quantitative high-throughput screening. Environ. Health Perspect. 2008, 116:284-291.